Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
lapatinib (tykerb) (1 trial)
m1-c6v1 (1 trial)
recombinant oncolytic virus m1 (1 trial)
Carcinoma (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Trials (2 total)
Trial APIs (3 total)